Schroder Investment Management Group’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-52,076	Closed	-$1.07M	–	1264
2023 Q3	$1.07M	Sell	52,076 -98,228	-65%	-$2.84M	﹤0.01%	1008
2023 Q2	$7.07M	Buy	150,304 +96,378	+179%	+$4.79M	0.01%	711
2023 Q1	$2.26M	Sell	53,926 -3,460	-6%	-$149K	﹤0.01%	932
2022 Q4	$2.19M	Buy	+57,386	New	+$2.19M	﹤0.01%	928
2022 Q1	–	Sell	-143	Closed	-$6K	–	1554
2021 Q4	$6K	Buy	143 +59	+70%	+$2.47K	﹤0.01%	1395
2021 Q3	$4K	Hold	84	–	–	﹤0.01%	1476
2021 Q2	$5K	Sell	84 -30,315	-100%	-$2.14M	﹤0.01%	1498
2021 Q1	$2.27M	Sell	30,399 -51,016	-63%	-$4.18M	﹤0.01%	987
2020 Q4	$7.04M	Buy	81,415 +6,251	+8%	+$461K	0.01%	725
2020 Q3	$4.39M	Buy	75,164 +14,611	+24%	+$741K	0.01%	748
2020 Q2	$2.52M	Buy	60,553 +39,045	+182%	+$1.42M	﹤0.01%	787
2020 Q1	$610K	Buy	+21,508	New	+$1.25M	﹤0.01%	963
2019 Q4	–	Sell	-1,239	Closed	-$177K	–	1336
2019 Q3	$177K	Buy	1,239 +402	+48%	+$67.2K	﹤0.01%	1157
2019 Q2	$153K	Sell	837 -1,183	-59%	-$202K	﹤0.01%	1103
2019 Q1	$321K	Sell	2,020 -630	-24%	-$91.2K	﹤0.01%	1038
2018 Q4	$254	Sell	2,650 -151	-5%	-$17.3K	﹤0.01%	1065
2018 Q3	$396K	Buy	2,801 +426	+18%	+$65.8K	﹤0.01%	1052
2018 Q2	$361K	Buy	+2,375	New	+$373K	﹤0.01%	1093